Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion type Assertion NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_head.
- NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion description "[Surprisingly, when we examined the bone marrow and peripheral mononuclear cells from patients with myelodysplastic syndrome (MDS) or leukemia secondary to MDS, we could still detect the exon-skipped form but little or none of the intact IRF-1 mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_provenance.
- NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion evidence source_evidence_literature NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_provenance.
- NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion SIO_000772 7936656 NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_provenance.
- NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion wasDerivedFrom befree-20140225 NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_provenance.
- NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_assertion wasGeneratedBy ECO_0000203 NP634521.RA5AdciavjHFC6vjriLkh82DMRLMgbLcy7BFbHF-LLWXo130_provenance.